Analystreport

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $96.00 price target on the stock.

Taro Pharmaceutical Industries Ltd. Ordinary Shares  (TARO) 
Last taro pharmaceutical industries ltd. ordinary shares earnings: 2/3 05:21 pm Check Earnings Report